Illumina said today it agreed to acquire the majority stake it does not already own in cancer blood test developer GRAIL for $8 billion in cash and stock, confirming nearly a week of speculation that ...

Test-driven development may be more talked about than practiced Your email has been sent Everyone is talking about test-driven development. Is anyone actually doing it? TDD has been embraced by the ...

The Federal Trade Commission ordered Illumina to divest its controversial acquisition of cancer test developer Grail. The commission said the deal would stifle competition and innovation in the U.S.

DUBLIN, Dec. 16, 2025 /PRNewswire/ -- BrowserStack, the world's leading software testing platform, today launched its AI-powered Test Failure Analysis Agent, an autonomous system that debugs test ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline. The conglomerate’s investment—which collectively ...

Apple sweetened the deal offered to developers for the early return of the Mac mini that they used to test macOS Big Sur running on Apple Silicon. Friday, the company responded to complaints that it ...

Self-healing tests became the QA industry's biggest bet in 2025. Vendors claim AI can fix broken automation overnight. Engineering teams are burning budgets on tools that supposedly eliminate ...

HackerRank for Work, a service that helps businesses send assessment tests to developer job candidates, is today launching the Test Health Dashboard, a machine learning-enhanced tool that helps ...